Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities

被引:50
|
作者
Xiang, Zheng [1 ]
Tu, Wenwei [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Lab Translat Immunol, Hong Kong, Hong Kong, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2017年 / 8卷
关键词
V gamma 9V delta 2-T cells; antitumor activity; pro-tumor activity; tumor immunity; tumor immunotherapy; DELTA-T-CELLS; TCR-GAMMA-DELTA; PRENYL PYROPHOSPHATE ANTIGENS; BREAST-CANCER PATIENTS; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; IMMUNE-RESPONSES; ZOLEDRONIC ACID; DENDRITIC-CELLS;
D O I
10.3389/fimmu.2017.01041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma 9V delta 2-T cells are considered as potent effector cells for tumor immunotherapy through directly killing tumor cells and indirectly regulating other innate and adaptive immune cells to establish antitumoral immunity. The antitumoral activity of V gamma 9V delta 2-T cells is governed by a complicated set of activating and inhibitory cell receptors. In addition, cytokine milieu in tumor microenvironment can also induce the pro-tumoral activities and functional plasticity of V gamma 9V delta 2-T cells. Here, we review the anti-versus pro-tumoral activities of V gamma 9V delta 2-T cells and discuss the mechanisms underlying the recognition, activation, differentiation and regulation of V gamma 9V delta 2-T cells in tumor immunosurveillance. The comprehensive understanding of the dual face of V gamma 9V delta 2-T cells in tumor immunology may improve the therapeutic efficacy and clinical outcomes of V gamma 9V delta 2-T cell-based tumor immunotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
    de Bruin, Renee C. G.
    Veluchamy, John P.
    Lougheed, Sinead M.
    Schneiders, Famke L.
    Lopez-Lastra, Silvia
    Lameris, Roeland
    Stam, Anita G.
    Sebestyen, Zsolt
    Kuball, Juergen
    Molthoff, Carla F. M.
    Hooijberg, Erik
    Roovers, Rob C.
    Di Santo, James P.
    Henegouwen, Paul M. P. van Bergen En
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [2] Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy
    Werter, Inge M.
    Schneiders, Famke L.
    Scotet, Emmanuel
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    ONCOIMMUNOLOGY, 2014, 3 (09)
  • [3] Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α
    Schneiders, Famke L.
    de Bruin, Renee C. G.
    Santegoets, Saskia J. A. M.
    Bonneville, Marc
    Scotet, Emmanuel
    Scheper, Rik J.
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CLINICAL IMMUNOLOGY, 2012, 142 (02) : 194 - 200
  • [4] Acquisition of antigen presenting cell functions by Vγ9Vα2-T cells requires trogocytosis
    Schneiders, Famke L.
    Santegoets, Saskia J. A. M.
    Scheper, Rik J.
    Verheul, Henk M. W.
    Bonneville, Marc
    Scotet, Emmanuel
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CANCER RESEARCH, 2012, 72
  • [5] CD1d-Restricted Antigen Presentation by Vγ9Vδ2-T Cells Requires Trogocytosis
    Schneiders, Famke L.
    Prodoehl, Jan
    Ruben, Jurjen M.
    O'Toole, Tom
    Scheper, Rik J.
    Bonneville, Marc
    Scotet, Emmanuel
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (08) : 732 - 740
  • [6] The effects of systemic treatment with aminobisphosphonates and statins on circulating Vγ9Vδ2-T cells in patients with advanced cancer
    Schneiders, Famke L.
    Huijts, Charlotte M.
    Reijm, Martine
    Bontkes, Hetty J.
    Verheul, Henk M. W.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    IMMUNOBIOLOGY, 2018, 223 (02) : 171 - 177
  • [7] Vγ9Vδ2 T cells in human legionellosis
    Kroca, M
    Johansson, A
    Sjöstedt, A
    Tärnvik, A
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (05) : 949 - 954
  • [8] Phosphoantigen recognition by Vγ9Vδ2 T cells
    Herrmann, Thomas
    Karunakaran, Mohindar Murugesh
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (11)
  • [9] A CD3 antibody distinguishes the V(gamma)9V delta 2-T cells from other T cells.
    Drbal, K
    Cerny, J
    Hilgert, I
    Horejsi, V
    TISSUE ANTIGENS, 1996, 48 (4-II): : TC409 - TC409
  • [10] Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells
    Hong Li
    Zheng Xiang
    Ting Feng
    Jinrong Li
    Yinping Liu
    Yingying Fan
    Qiao Lu
    Zhongwei Yin
    Meixing Yu
    Chongyang Shen
    Wenwei Tu
    Cellular & Molecular Immunology, 2013, 10 : 159 - 164